Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Well Lead Medical CoSHSE:603309 +0.17%84 Shareholder Yield % is 2.40% as of Jun. 2026, which is 193% above its 10-year median of 0.82. GuruFocus rates SHSE:603309 with a GF Score™ of 84/100 and a GF Value™ of ¥14.48 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Well Lead Medical Co ranks better than 70.83% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Well Lead Medical Co's Shareholder Yield % was 2.40%.
Well Lead Medical Co (SHSE:603309) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Well Lead Medical Co Shareholder Yield % Related Terms
Well Lead Medical Co Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Well Lead Medical Co's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603309 vs ISRG, BDX, MDLN: Shareholder Yield % Comparison
For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Well Lead Medical Co Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Well Lead Medical Co's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Well Lead Medical Co (SHSE:603309) has a Shareholder Yield % of 2.40% as of Jun. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Well Lead Medical Co and its competitors. This is 193% above median its historical median of 0.82. According to the industry distribution chart, Well Lead Medical Co ranks #238 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 29.2%.
Is Well Lead Medical Co's Shareholder Yield % too high?
Well Lead Medical Co's current Shareholder Yield % of 2.40% is 193% above median its 10-year median of 0.82. The Medical Devices & Instruments industry median Shareholder Yield % is 0.19. Well Lead Medical Co's value of 2.40% is 1197.3% above this industry median. Based on the distribution chart, Well Lead Medical Co ranks #238 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Well Lead Medical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Well Lead Medical Co's Shareholder Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Well Lead Medical Co ranks #238 out of 816 companies for Shareholder Yield %. This puts Well Lead Medical Co in the upper half of its industry. The industry median Shareholder Yield % is 0.19. Well Lead Medical Co's value of 2.40% is 1197.3% above this benchmark. While the company's 10-year median is 0.82 vs. the industry median of 0.19, Well Lead Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.19, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Well Lead Medical Co's current Shareholder Yield % of 2.40% is 1197.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Well Lead Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Well Lead Medical Co's current Shareholder Yield % is 2.40%, which is 193% above median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Well Lead Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Well Lead Medical Co (SHSE:603309) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.48, compared to a current price of ¥11.59 — trading 20% below its estimated fair value. The current Shareholder Yield % is 2.40%, which is 193% above median its 10-year median of 0.82 and 1197.3% above the Medical Devices & Instruments industry median of 0.19. Well Lead Medical Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Well Lead Medical Co (SHSE:603309), the current Shareholder Yield % is 2.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?
Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued.
The current stock price of ¥11.59 is trading 20% below its estimated GF Value™ of ¥14.48.
GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603309:
Shareholder Yield %: 2.40% (193% above median its 10-year median of 0.82)
GF Value™: ¥14.48 vs. price of ¥11.59 (20% below fair value)
Industry Position: 1197.3% above the Medical Devices & Instruments median (#238 of 816)
No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
84GF Score
Get the complete analysis for SHSE:603309
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603309 has been successfully added to your 
